Supplementary Table S1. Results of the disproportionality analysis for “diffuse alopecia” before and after excluding the French levothyroxine precautionary reports. Only medicinal products with a number of ICSRs greater than or equal to three are represented. Positive signals of disproportionate reporting are represented in bold. ICSRs: individual cases safety reports; ROR: reporting odds ratio; ROR05: ROR lower boundary 95% confidence interval. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Khouri et al. (2018) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: